强强联合,持久获益——系统性治疗失败的MSI-H/dMMR转移性结直肠癌的免疫联合治疗
Strong Combination, Long-Lasting Benefit: Immunotherapy Combination for MSI-H/dMMR Metastatic Colorectal Cancer That Has Failed Systemic Treatment
强强联合,持久获益——系统性治疗失败的MSI-H/dMMR转移性结直肠癌的免疫联合治疗 |
|
评价者：陈治宇 |
Strong Combination, Long-Lasting Benefit: Immunotherapy Combination for MSI-H/dMMR Metastatic Colorectal Cancer That Has Failed Systemic Treatment |
| |